acarix

Corporate Information, IR, News, Other Corporate Information, Swedish

November 18, 2024

09 May 2023

Acarix och American College of Cardiology samarbetar gällande första versionens kliniska protokoll för CADScor System

New York och Washington (9 maj 2023) -- Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, tillkännager idag, i sa...

Continue reading

acarix

Corporate Information, English, IR, News, Other Corporate Information

November 18, 2024

03 May 2023

Helen Ljungdahl Round, Acarix President & CEO presents at Redeye Investor Forum

On May 4th at 14.40 Helen Ljungdahl Round, Acarix President & CEO, presents the latest developments in the company at the Redeye In...

Continue reading

acarix

Corporate Information, IR, News, Other Corporate Information, Swedish

November 18, 2024

03 May 2023

Helen Ljungdahl Round, Acarix VD & koncernchef presenterar på Redeye Investor Forum

Den 4 maj kl 14.40 presenterar Helen Ljungdahl Round, Acarix VD & koncernchef, den senaste utvecklingen i bolaget på Redeye I...

Continue reading

acarix

Corporate Information, English, IR, News, Other Corporate Information

November 18, 2024

02 May 2023

Acarix to present at the 2023 Aktiespararna Share Day in Stockholm

Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces that the company will present at the 2023 Aktiespararna Share ...

Continue reading

acarix

Corporate Information, IR, News, Other Corporate Information, Swedish

November 18, 2024

02 May 2023

Acarix presenterar på Aktiespararnas Aktiedag 2023 i Stockholm

Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, meddelar att bolaget kommer att presentera på Aktiespararnas A...

Continue reading

acarix

Corporate Information, English, IR, Listing Regulation, News, Other Corporate Information, Regulatory

November 18, 2024

02 May 2023

The exercise period for Acarix warrants of series 2022:U begins today

In December 2022, Acarix AB (publ) (“Acarix” or the “Company”) carried out a rights issue of shares and warrant...

Continue reading

acarix

Corporate Information, IR, Listing Regulation, News, Other Corporate Information, Regulatory, Swedish

November 18, 2024

02 May 2023

Idag inleds nyttjandeperioden för Acarix teckningsoptioner av serie 2022:U

Acarix AB (publ) (“Acarix” eller “Bolaget”) genomförde under december 2022 en företrädesemission...

Continue reading

acarix

Annual, English, IR, Listing Regulation, News, Regulatory, Report

November 18, 2024

20 Apr 2023

Acarix AB’s Annual Report 2022

Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announces that the Annual Report for 2022 is available as a pdf on...

Continue reading

acarix

Annual, IR, Listing Regulation, News, Regulatory, Report, Swedish

November 18, 2024

20 Apr 2023

Acarix AB’s Årsredovisning 2022

Acarix, ledare inom akustisk och AI-baserad hjärtdiagnostik, meddelar idag att årsredovisning för 2022 finns tillgä...

Continue reading

acarix

Corporate Information, English, General meeting, IR, Listing Regulation, News, Notice, Regulatory

November 18, 2024

11 Apr 2023

Notice of Annual General Meeting in Acarix AB

The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convened to the annual general meeting to be held on T...

Continue reading

acarix

Corporate Information, General meeting, IR, Listing Regulation, News, Notice, Regulatory, Swedish

November 18, 2024

11 Apr 2023

Kallelse till årsstämma i Acarix AB

Aktieägarna i Acarix AB, org.nr 559009-0667, ("Bolaget") kallas härmed till årsstämma torsdagen den 11 maj 2023 kl...

Continue reading

acarix

Corporate Action, English, IR, Issuance, MAR, News, Regulatory, Shares

November 18, 2024

04 Apr 2023

Acarix carries out a directed share issue amounting to approximately SEK 9.5 million

THIS PRESS RELEASE IS NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, ...

Continue reading